James B. Pekarek Sells 20,000 Shares of Agiliti, Inc. (NYSE:AGTI) Stock

Agiliti, Inc. (NYSE:AGTIGet Rating) CFO James B. Pekarek sold 20,000 shares of the stock in a transaction dated Monday, May 2nd. The stock was sold at an average price of $20.17, for a total transaction of $403,400.00. Following the sale, the chief financial officer now directly owns 220,256 shares in the company, valued at approximately $4,442,563.52. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink.

Shares of AGTI stock opened at $20.40 on Thursday. Agiliti, Inc. has a 12-month low of $13.56 and a 12-month high of $26.36. The company has a quick ratio of 1.45, a current ratio of 1.72 and a debt-to-equity ratio of 1.31. The firm has a fifty day moving average of $19.98 and a 200-day moving average of $20.62. The company has a market capitalization of $2.67 billion and a price-to-earnings ratio of 107.37.

Agiliti (NYSE:AGTIGet Rating) last released its earnings results on Tuesday, March 8th. The company reported $0.23 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $0.19 by $0.04. The firm had revenue of $290.48 million during the quarter, compared to analysts’ expectations of $268.54 million. Agiliti had a return on equity of 15.02% and a net margin of 2.31%. On average, equities analysts expect that Agiliti, Inc. will post 0.85 EPS for the current year.

AGTI has been the topic of a number of research analyst reports. The Goldman Sachs Group decreased their price objective on shares of Agiliti from $32.00 to $28.00 and set a “buy” rating on the stock in a report on Friday, March 11th. Citigroup cut their target price on shares of Agiliti from $28.00 to $25.00 and set a “buy” rating on the stock in a research report on Wednesday, March 9th. Zacks Investment Research downgraded shares of Agiliti from a “hold” rating to a “sell” rating in a research report on Tuesday, March 15th. Morgan Stanley cut their target price on shares of Agiliti from $30.00 to $24.00 and set an “overweight” rating on the stock in a research report on Thursday, March 10th. Finally, Raymond James cut their target price on shares of Agiliti from $30.00 to $25.00 and set an “outperform” rating on the stock in a research report on Friday, March 11th. One equities research analyst has rated the stock with a sell rating, one has issued a hold rating and nine have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, Agiliti has a consensus rating of “Buy” and an average price target of $23.00.

Hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Victory Capital Management Inc. bought a new position in shares of Agiliti during the 1st quarter worth approximately $243,000. Shell Asset Management Co. increased its stake in Agiliti by 76.0% in the 1st quarter. Shell Asset Management Co. now owns 13,324 shares of the company’s stock valued at $281,000 after buying an additional 5,754 shares during the last quarter. First Quadrant LLC CA bought a new stake in Agiliti during the 1st quarter worth about $38,000. Norges Bank acquired a new position in shares of Agiliti during the 4th quarter worth about $6,647,000. Finally, Barclays PLC grew its holdings in shares of Agiliti by 197.0% in the 4th quarter. Barclays PLC now owns 28,529 shares of the company’s stock valued at $661,000 after acquiring an additional 18,924 shares in the last quarter. Hedge funds and other institutional investors own 99.27% of the company’s stock.

About Agiliti (Get Rating)

Agiliti, Inc provides healthcare technology management and service solutions to the healthcare industry in the United States. The company offers onsite managed services, including programs for the management, reprocessing, and logistics of medical equipment at individual facilities and integrated delivery networks to monitor and adjust equipment quantities and availability to address fluctuations in patient census and acuity.

Featured Stories

Insider Buying and Selling by Quarter for Agiliti (NYSE:AGTI)

Receive News & Ratings for Agiliti Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agiliti and related companies with MarketBeat.com's FREE daily email newsletter.